Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03617068
Other study ID # 05
Secondary ID
Status Completed
Phase Phase 3
First received
Last updated
Start date February 6, 2017
Est. completion date May 14, 2018

Study information

Verified date June 2018
Source Fakultas Kedokteran Universitas Indonesia
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Empirically, mosturizer is used to prevent and treat many occupational dermatoses that has skin barrier impairment. Evidence based medicine about the effectivity of mosturizer in occupational dermatoses is limited. Coconut oil is one of traditional substance that is used as a skin care. There is study shows that coconut oil is effective for atopic dermatitis treatment in children. Other studies are needed to assess the effectivity coconut oil mosturizer cream to overcome occupational hand dermatitis.


Description:

The aim of this study is to measure the effectivenes of coconut oil cream for batik workers who suffer from occupational hand dermatitis. The gloves that used as a protective equipment are made from rubber which have its own limitations. Therefore other interventions are needed to improve barrier skin.


Recruitment information / eligibility

Status Completed
Enrollment 32
Est. completion date May 14, 2018
Est. primary completion date May 3, 2018
Accepts healthy volunteers No
Gender Male
Age group 25 Years to 60 Years
Eligibility Inclusion Criteria:

- signing the informed consent document before the study start

- adult population include patients between the ages of 18 and 64 years who work in the dyeing and washing process more than 6 months.

- suffering from occupational hand dermatitis that meet Mathias Criteria.

- willing to obey the research protocol

- willing to fill in diary periodically

Exclusion Criteria:

- having history of allergy or irritation caused by coconut oil or other mosturizer

- suffering from symptoms including edema, exudation, crust, fissures, liver problems, and signs of infection

- on corticosteroid treatment ( medium to high potency) or on systemic immunosuppressive therapy

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Cocos Nucifera Whole
Applying the Cocos Nucifera Whole cream for 2 weeks, on both of arms. We evaluated the score of hand dermatitis using Hand Eczema Score Index ( HECSI), transepidermal water loss (TEWL), and Skin capacitance
Cocos Nucifera Whole
For dermatopharmacokinetic evaluation using tape/ skin stripping

Locations

Country Name City State
Indonesia Faculty of Medicine Universitas Indonesia Jakarta Pusat Jakarta

Sponsors (1)

Lead Sponsor Collaborator
Fakultas Kedokteran Universitas Indonesia

Country where clinical trial is conducted

Indonesia, 

Outcome

Type Measure Description Time frame Safety issue
Primary clinical improvement of hand dermatitis measured by Hand Eczema Severity Index (HECSI) after using coconut oil Batik workers who had hand dermatitis was measured using HECSI score before and after intervention with coconut oil cream. They used the cream twice daily for 14 days 14 days
Secondary Transepidermal water loss (TEWL) TEWL is the amount of water that passively evaporates through skin to the external environment 14 days
Secondary Skin capacitance Skin capacitance depends on the water content of the stratum corneum 14 days
See also
  Status Clinical Trial Phase
Completed NCT00124436 - Follow-up Efficacy and Safety of Alitretinoin in Severe Chronic Hand Dermatitis Phase 3
Completed NCT04136574 - Hand Dermatitis in the Care and Hospital Staff
Completed NCT05471934 - Satisfaction Survey - Cicaplast Mains
Completed NCT00124475 - Efficacy and Safety of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis Phase 3
Completed NCT00890968 - Safety and Efficacy Study of Triamcinolone Acetonide DuraPeel to Treat Hand Dermatitis Phase 2
Completed NCT00309621 - Safety and Efficacy of a Retinoid for the Treatment of Severe Chronic Hand Dermatitis Phase 3